Baseline Alkaline Phosphatase Impacts Response Rates in Primary Biliary Cholangitis: Exploring Response to Elafibranor in ELATIVE.

Saved in:
Bibliographic Details
Title: Baseline Alkaline Phosphatase Impacts Response Rates in Primary Biliary Cholangitis: Exploring Response to Elafibranor in ELATIVE.
Authors: Levy C; Schiff Center for Liver Diseases, University of Miami, Miami, Florida, USA.; Division of Digestive Health and Liver Diseases, University of Miami School of Medicine, Miami, Florida, USA., Bowlus CL; Division of Gastroenterology and Hepatology, UC Davis School of Medicine, Sacramento, California, USA., Lawitz E; The Texas Liver Institute, University of Texas Health, San Antonio, Texas, USA., Antunes N; Ipsen, Cambridge, Massachusetts, USA., Miller B; Ipsen, Cambridge, Massachusetts, USA., Shu J; Ipsen, Cambridge, Massachusetts, USA., Zein CO; Ipsen, Cambridge, Massachusetts, USA., Kowdley KV; Liver Institute Northwest, Seattle, WA, USA.
Source: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2026 May; Vol. 46 (5), pp. e70630.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print Cited Medium: Internet ISSN: 1478-3231 (Electronic) Linking ISSN: 14783223 NLM ISO Abbreviation: Liver Int Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1478-3231
DOI:10.1111/liv.70630